Literature DB >> 10447952

Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships.

N R Natale1, M E Rogers, R Staples, D J Triggle, A Rutledge.   

Abstract

A series of 4-isoxazolyl-1,4-dihydropyridines bearing lipophilic side chains at the C-5 position of the isoxazole ring have been prepared. The calcium channel antagonistic activity of these compounds has been evaluated. A hypothetical model for binding of these compounds in the calcium channel is proposed, and the validity of this model is evaluated based on the SAR of this series of calcium binding, especially for the two most active derivatives, 1a, g. The solid-state structure for the most active compound, 1a, has also been determined, and its important features are reported.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447952     DOI: 10.1021/jm980439q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Lanthanide and asymmetric catalyzed syntheses of sterically hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones.

Authors:  Scott A Steiger; Chun Li; Charles F Campana; Nicholas R Natale
Journal:  Tetrahedron Lett       Date:  2016-01-20       Impact factor: 2.415

2.  Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.

Authors:  Scott A Steiger; Chun Li; Donald S Backos; Philip Reigan; N R Natale
Journal:  Bioorg Med Chem       Date:  2017-04-08       Impact factor: 3.641

3.  4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter.

Authors:  Victoria Hulubei; Scott B Meikrantz; David A Quincy; Tina Houle; John I McKenna; Mark E Rogers; Scott Steiger; N R Natale
Journal:  Bioorg Med Chem       Date:  2012-09-25       Impact factor: 3.641

4.  Fluorescent probes of the isoxazole-dihydropyridine scaffold: MDR-1 binding and homology model.

Authors:  Monika I Szabon-Watola; Sarah V Ulatowski; Kathleen M George; Christina D Hayes; Scott A Steiger; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-12-04       Impact factor: 2.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.